Market Research Report
Global Drug Eluting Balloons (DEBs) Market 2020-2024
|Published by||TechNavio (Infiniti Research Ltd.)||Product code||518873|
|Published||Content info||120 Pages
Delivery time: 1-2 business days
|Global Drug Eluting Balloons (DEBs) Market 2020-2024|
|Published: May 2, 2020||Content info: 120 Pages||
Technavio has been monitoring the drug eluting balloons (DEBs) market and it is poised to grow by $ 476.64 mn during 2020-2024 progressing at a CAGR of 13% during the forecast period. Our reports on drug eluting balloons (DEBs) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the shift toward MI techniques and increasing healthcare expenditure. In addition, demand for cath labs is anticipated to boost the growth of the market as well.
The drug eluting balloons (DEBs) market analysis includes product segment and geographic landscape.
Technavio's ‘ drug eluting balloons (DEBs) market ’ is segmented as below:
By Geographic Landscape:
This study identifies favorable reimbursement policies as one of the prime reasons driving the drug eluting balloons (DEBs) market growth during the next few years. Also, the threat from conventional balloon catheters and drug eluting stenting procedure and increase in the number of clinical trials for DEBs will lead to sizable demand in the market.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our drug eluting balloons (DEBs) market covers the following areas:
Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading drug eluting balloons (DEBs) market vendors that include B. Braun Melsungen AG, Becton, Dickinson and Co., BIOTRONIK SE & Co. KG, Boston Scientific Corp., Cardinal Health Inc., Cardionovum GmbH, COOK MEDICAL LLC, Koninklijke Philips NV, Medtronic Plc, and Opto Circuits (India) Ltd. Also, the drug eluting balloons (DEBs) market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.